HealthLynked (HLYK) Net Income towards Common Stockholders (2016 - 2026)

HealthLynked (HLYK) has 11 years of Net Income towards Common Stockholders data on file, last reported at -$1.7 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$1.7 million, down 57.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.2 million (up 30.7% YoY), and the FY2025 annual result was -$2.1 million, up 54.82% from the prior year.
• Net Income towards Common Stockholders slipped to -$1.7 million in Q1 2026 per HLYK's latest filing, from -$530894.0 in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $1.5 million in Q1 2023 and troughed at -$4.4 million in Q4 2022.
• A 5-year average of -$1.1 million and a median of -$1.1 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders surged 215.55% in 2023, then slumped 855.47% in 2024.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.4 million in 2022, then jumped by 70.53% to -$1.3 million in 2023, then surged by 41.76% to -$748774.0 in 2024, then climbed by 29.1% to -$530894.0 in 2025, then slumped by 212.24% to -$1.7 million in 2026.
• Business Quant data shows HLYK's Net Income towards Common Stockholders at -$1.7 million in Q1 2026, -$530894.0 in Q4 2025, and -$529586.0 in Q3 2025.